A Mutant Library Approach to Identify Improved Meningococcal Factor H Binding Protein Vaccine Antigens.

Factor H binding protein (FHbp) is a virulence factor used by meningococci to evade the host complement system. FHbp elicits bactericidal antibodies in humans and is part of two recently licensed vaccines. Using human complement Factor H (FH) transgenic mice, we previously showed that binding of FH...

Full description

Bibliographic Details
Main Authors: Monica Konar, Raffaella Rossi, Helen Walter, Rolando Pajon, Peter T Beernink
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4461315?pdf=render
id doaj-ca6ad6fa5cb3448298c8c2e367578994
record_format Article
spelling doaj-ca6ad6fa5cb3448298c8c2e3675789942020-11-25T01:45:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01106e012818510.1371/journal.pone.0128185A Mutant Library Approach to Identify Improved Meningococcal Factor H Binding Protein Vaccine Antigens.Monica KonarRaffaella RossiHelen WalterRolando PajonPeter T BeerninkFactor H binding protein (FHbp) is a virulence factor used by meningococci to evade the host complement system. FHbp elicits bactericidal antibodies in humans and is part of two recently licensed vaccines. Using human complement Factor H (FH) transgenic mice, we previously showed that binding of FH decreased the protective antibody responses to FHbp vaccination. Therefore, in the present study we devised a library-based method to identify mutant FHbp antigens with very low binding of FH. Using an FHbp sequence variant in one of the two licensed vaccines, we displayed an error-prone PCR mutant FHbp library on the surface of Escherichia coli. We used fluorescence-activated cell sorting to isolate FHbp mutants with very low binding of human FH and preserved binding of control anti-FHbp monoclonal antibodies. We sequenced the gene encoding FHbp from selected clones and introduced the mutations into a soluble FHbp construct. Using this approach, we identified several new mutant FHbp vaccine antigens that had very low binding of FH as measured by ELISA and surface plasmon resonance. The new mutant FHbp antigens elicited protective antibody responses in human FH transgenic mice that were up to 20-fold higher than those elicited by the wild-type FHbp antigen. This approach offers the potential to discover mutant antigens that might not be predictable even with protein structural information and potentially can be applied to other microbial vaccine antigens that bind host proteins.http://europepmc.org/articles/PMC4461315?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Monica Konar
Raffaella Rossi
Helen Walter
Rolando Pajon
Peter T Beernink
spellingShingle Monica Konar
Raffaella Rossi
Helen Walter
Rolando Pajon
Peter T Beernink
A Mutant Library Approach to Identify Improved Meningococcal Factor H Binding Protein Vaccine Antigens.
PLoS ONE
author_facet Monica Konar
Raffaella Rossi
Helen Walter
Rolando Pajon
Peter T Beernink
author_sort Monica Konar
title A Mutant Library Approach to Identify Improved Meningococcal Factor H Binding Protein Vaccine Antigens.
title_short A Mutant Library Approach to Identify Improved Meningococcal Factor H Binding Protein Vaccine Antigens.
title_full A Mutant Library Approach to Identify Improved Meningococcal Factor H Binding Protein Vaccine Antigens.
title_fullStr A Mutant Library Approach to Identify Improved Meningococcal Factor H Binding Protein Vaccine Antigens.
title_full_unstemmed A Mutant Library Approach to Identify Improved Meningococcal Factor H Binding Protein Vaccine Antigens.
title_sort mutant library approach to identify improved meningococcal factor h binding protein vaccine antigens.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description Factor H binding protein (FHbp) is a virulence factor used by meningococci to evade the host complement system. FHbp elicits bactericidal antibodies in humans and is part of two recently licensed vaccines. Using human complement Factor H (FH) transgenic mice, we previously showed that binding of FH decreased the protective antibody responses to FHbp vaccination. Therefore, in the present study we devised a library-based method to identify mutant FHbp antigens with very low binding of FH. Using an FHbp sequence variant in one of the two licensed vaccines, we displayed an error-prone PCR mutant FHbp library on the surface of Escherichia coli. We used fluorescence-activated cell sorting to isolate FHbp mutants with very low binding of human FH and preserved binding of control anti-FHbp monoclonal antibodies. We sequenced the gene encoding FHbp from selected clones and introduced the mutations into a soluble FHbp construct. Using this approach, we identified several new mutant FHbp vaccine antigens that had very low binding of FH as measured by ELISA and surface plasmon resonance. The new mutant FHbp antigens elicited protective antibody responses in human FH transgenic mice that were up to 20-fold higher than those elicited by the wild-type FHbp antigen. This approach offers the potential to discover mutant antigens that might not be predictable even with protein structural information and potentially can be applied to other microbial vaccine antigens that bind host proteins.
url http://europepmc.org/articles/PMC4461315?pdf=render
work_keys_str_mv AT monicakonar amutantlibraryapproachtoidentifyimprovedmeningococcalfactorhbindingproteinvaccineantigens
AT raffaellarossi amutantlibraryapproachtoidentifyimprovedmeningococcalfactorhbindingproteinvaccineantigens
AT helenwalter amutantlibraryapproachtoidentifyimprovedmeningococcalfactorhbindingproteinvaccineantigens
AT rolandopajon amutantlibraryapproachtoidentifyimprovedmeningococcalfactorhbindingproteinvaccineantigens
AT petertbeernink amutantlibraryapproachtoidentifyimprovedmeningococcalfactorhbindingproteinvaccineantigens
AT monicakonar mutantlibraryapproachtoidentifyimprovedmeningococcalfactorhbindingproteinvaccineantigens
AT raffaellarossi mutantlibraryapproachtoidentifyimprovedmeningococcalfactorhbindingproteinvaccineantigens
AT helenwalter mutantlibraryapproachtoidentifyimprovedmeningococcalfactorhbindingproteinvaccineantigens
AT rolandopajon mutantlibraryapproachtoidentifyimprovedmeningococcalfactorhbindingproteinvaccineantigens
AT petertbeernink mutantlibraryapproachtoidentifyimprovedmeningococcalfactorhbindingproteinvaccineantigens
_version_ 1725023315920158720